1. Home
  2. CRCT vs COLL Comparison

CRCT vs COLL Comparison

Compare CRCT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$5.19

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
COLL
Founded
1969
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CRCT
COLL
Price
$5.19
$48.67
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
3
6
Target Price
$4.18
$47.50
AVG Volume (30 Days)
492.2K
515.8K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
18.27%
N/A
EPS Growth
27.98
N/A
EPS
0.37
1.63
Revenue
$714,492,000.00
$757,067,000.00
Revenue This Year
$1.06
$26.35
Revenue Next Year
N/A
$3.67
P/E Ratio
$14.07
$29.92
Revenue Growth
N/A
26.34
52 Week Low
$3.94
$23.23
52 Week High
$7.33
$49.16

Technical Indicators

Market Signals
Indicator
CRCT
COLL
Relative Strength Index (RSI) 59.44 70.71
Support Level $4.65 $46.15
Resistance Level $5.27 $49.16
Average True Range (ATR) 0.14 1.32
MACD 0.07 -0.16
Stochastic Oscillator 87.90 92.11

Price Performance

Historical Comparison
CRCT
COLL

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: